LDA Definition 1 | LDA Definition 2 | Proportion of Patients Achieving LDA 2 but Not LDA 1, n/N (%) | Proportion of Patients Achieving LDA 1 but Not LDA 2, n/N (%) | κ Coefficient* |
---|---|---|---|---|
MDA 5/7 | DAPSA LDA | 184/669 (27.5) | 10/669 (1.5) | 0.45 |
MDA skin | DAPSA LDA | 346/668 (51.8) | 7/668 (1.0) | 0.15 |
MDA joint | DAPSA LDA | 225/668 (33.7) | 1/665 (0.1) | 0.39 |
MDA joint + skin | DAPSA LDA | 373/669 (55.8) | 1/669 (0.1) | 0.13 |
MDA 5/7 | cDAPSA LDA | 183/676 (27.1) | 10/676 (1.5) | 0.45 |
MDA skin | cDAPSA LDA | 347/675 (51.4) | 7/675 (1.0) | 0.16 |
MDA joint | cDAPSA LDA | 225/675 (33.3) | 1/675 (0.1) | 0.40 |
MDA joint + skin | cDAPSA LDA | 375/676 (55.5) | 1/676 (0.1) | 0.13 |
↵* From κ test of agreement between LDA definition 1 and definition 2. LDA: low disease activity; MDA: minimal disease activity; DAPSA: Disease Activity for Psoriatic Arthritis; cDAPSA: clinical DAPSA.